Mesothelioma

"Mesothelioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)

Descriptor ID	D008654
MeSH Number(s)	C04.557.470.035.510 C04.557.470.660.510
Concept/Terms	Mesothelioma Mesothelioma Mesotheliomas

Below are MeSH descriptors whose meaning is more general than "Mesothelioma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Adenoma [C04.557.470.035]
Mesothelioma [C04.557.470.035.510]
Neoplasms, Mesothelial [C04.557.470.660]
Mesothelioma [C04.557.470.660.510]

Below are MeSH descriptors whose meaning is more specific than "Mesothelioma".

Mesothelioma
Mesothelioma, Cystic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mesothelioma" by people in this website by year, and whether "Mesothelioma" was a major or minor topic of these publications.

Bar chart showing 64 publications over 26 distinct years, with a maximum of 6 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1999	1	0	1
2000	0	1	1
2001	1	0	1
2002	1	0	1
2003	1	1	2
2004	3	0	3
2005	1	0	1
2006	1	1	2
2007	2	0	2
2009	3	0	3
2010	0	1	1
2011	2	0	2
2012	2	0	2
2013	3	0	3
2014	6	0	6
2015	2	0	2
2016	2	0	2
2017	3	0	3
2018	5	0	5
2019	5	0	5
2020	4	1	5
2021	1	0	1
2022	3	0	3
2023	3	0	3
2024	2	1	3

Below are the most recent publications written about "Mesothelioma" by people in Profiles.

Andretta E, Costa A, Ventura E, Quintiliani M, Damiano S, Giordano A, Morrione A, Ciarcia R. Capsaicin Exerts Antitumor Activity in Mesothelioma Cells. Nutrients. 2024 Nov 01; 16(21).

View in: PubMed
Kadariya Y, Sementino E, Ruan M, Cheung M, Hadikhani P, Osmanbeyoglu HU, Klein-Szanto AJ, Cai K, Testa JR. Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment. Cancer Res Commun. 2024 04 08; 4(4):1004-1015.

View in: PubMed
Inaguma S, Wang C, Ito S, Ueki A, Lasota J, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okon K, Biernat W, Takiguchi S, Schrump DS, Miettinen M, Takahashi S. Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment. Pathobiology. 2024; 91(5):313-325.

View in: PubMed
Ventura E, Belfiore A, Iozzo RV, Giordano A, Morrione A. Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells. Am J Physiol Cell Physiol. 2023 08 01; 325(2):C391-C405.

View in: PubMed
Nair NU, Jiang Q, Wei JS, Misra VA, Morrow B, Kesserwan C, Hermida LC, Lee JS, Mian I, Zhang J, Lebensohn A, Miettinen M, Sengupta M, Khan J, Ruppin E, Hassan R. Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. Cell Rep Med. 2023 02 21; 4(2):100938.

View in: PubMed
Inaguma S, Ueki A, Lasota J, Komura M, Sheema AN, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okon K, Biernat W, Schrump DS, Hassan R, Miettinen M, Takahashi S. CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma. J Pathol Clin Res. 2023 05; 9(3):195-207.

View in: PubMed
Ventura E, Xie C, Buraschi S, Belfiore A, Iozzo RV, Giordano A, Morrione A. Complexity of progranulin mechanisms of action in mesothelioma. J Exp Clin Cancer Res. 2022 Dec 05; 41(1):333.

View in: PubMed
Iczkowski KA. Malignant Mesothelioma of Tunica Vaginalis Testis: Update for 2022. Adv Anat Pathol. 2023 Jul 01; 30(4):259-261.

View in: PubMed
Correale P, Pentimalli F, Nardone V, Giordano A, Mutti L. CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? Lancet Oncol. 2022 01; 23(1):e13.

View in: PubMed
Hu ZI, Miettinen M, Quezado M, Lebensohn AP, Aldape K, Agra M, Wagner C, Mallory Y, Hassan R, Ghafoor A. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations. J Thorac Oncol. 2022 03; 17(3):461-466.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement